RU2018102087A3 - - Google Patents

Download PDF

Info

Publication number
RU2018102087A3
RU2018102087A3 RU2018102087A RU2018102087A RU2018102087A3 RU 2018102087 A3 RU2018102087 A3 RU 2018102087A3 RU 2018102087 A RU2018102087 A RU 2018102087A RU 2018102087 A RU2018102087 A RU 2018102087A RU 2018102087 A3 RU2018102087 A3 RU 2018102087A3
Authority
RU
Russia
Application number
RU2018102087A
Other versions
RU2741000C2 (ru
RU2018102087A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2018102087A publication Critical patent/RU2018102087A/ru
Publication of RU2018102087A3 publication Critical patent/RU2018102087A3/ru
Application granted granted Critical
Publication of RU2741000C2 publication Critical patent/RU2741000C2/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/88Carboxylic acid amides having nitrogen atoms of carboxamide groups bound to an acyclic carbon atom and to a carbon atom of a six-membered aromatic ring wherein at least one ortho-hydrogen atom has been replaced
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/422Oxazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU2018102087A 2015-06-22 2016-06-21 Производное 1,4-дизамещенного имидазола RU2741000C2 (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2015-125174 2015-06-22
JP2015125174 2015-06-22
JP2015-244856 2015-12-16
JP2015244856 2015-12-16
PCT/JP2016/068423 WO2016208591A1 (ja) 2015-06-22 2016-06-21 1,4-ジ置換イミダゾール誘導体

Publications (3)

Publication Number Publication Date
RU2018102087A RU2018102087A (ru) 2019-07-23
RU2018102087A3 true RU2018102087A3 (ru) 2019-12-25
RU2741000C2 RU2741000C2 (ru) 2021-01-22

Family

ID=57584875

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018102087A RU2741000C2 (ru) 2015-06-22 2016-06-21 Производное 1,4-дизамещенного имидазола

Country Status (13)

Country Link
US (3) US10807945B2 (ru)
EP (1) EP3312170A4 (ru)
JP (1) JP6692354B2 (ru)
KR (1) KR20180028456A (ru)
CN (1) CN107922386B (ru)
AU (1) AU2016284398C1 (ru)
CA (1) CA2990583A1 (ru)
HK (1) HK1248226A1 (ru)
PH (1) PH12017502388A1 (ru)
RU (1) RU2741000C2 (ru)
SG (1) SG11201710695XA (ru)
TW (1) TW201713642A (ru)
WO (1) WO2016208591A1 (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016284398C1 (en) * 2015-06-22 2021-01-07 Sumitomo Dainippon Pharma Co., Ltd. 1,4-disubstituted imidazole derivative
AU2016284399A1 (en) 2015-06-22 2018-02-01 Sumitomo Dainippon Pharma Co., Ltd. Bicyclic heterocyclic amide derivative
US10898469B2 (en) 2016-02-26 2021-01-26 Sumitomo Dainippon Pharma Co., Ltd. Imidazolylamide derivative
US11434472B2 (en) 2016-12-20 2022-09-06 Sumitomo Pharma Co., Ltd. Agent for removing undifferentiated iPS cells
EP3560494A4 (en) * 2016-12-20 2020-08-05 Sumitomo Dainippon Pharma Co., Ltd. MEDICINAL PRODUCT TARGETING A CARCINOUS STEM CELL
JP6775483B2 (ja) * 2016-12-20 2020-10-28 大日本住友製薬株式会社 1,4−ジ置換イミダゾール誘導体からなる医薬
KR20200135401A (ko) 2018-03-20 2020-12-02 다이니뽄 스미토모 세이야쿠 가부시키가이샤 디히드로크로멘 유도체
IL277794B2 (en) * 2018-04-06 2024-02-01 Black Belt Tx Ltd ATF6 inhibitors and uses thereof
JP7287929B2 (ja) * 2019-09-25 2023-06-06 住友ファーマ株式会社 ジヒドロクロメン誘導体を含有する医薬

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5359664A (en) * 1976-11-10 1978-05-29 Sumitomo Chem Co Ltd Novel imidazole derivatives
US4140788A (en) * 1976-11-10 1979-02-20 Sumitomo Chemical Company, Limited N-Substituted imidazolecarboxamide derivatives
WO1997015567A1 (de) * 1995-10-20 1997-05-01 Dr. Karl Thomae Gmbh 5-gliedrige heterocyclen, diese verbindungen enthaltende arzneimittel und deren verwendung sowie verfahren zu ihrer herstellung
NZ502752A (en) 1997-07-15 2001-01-26 Japan Energy Corp Purine derivatives and their use in the treatment of nephritis
GEP20084420B (en) * 2004-03-23 2008-07-10 Pfizer Prod Inc Use of imidazole compounds for the treatment of neurodegenerative disorders
SE0401653D0 (sv) 2004-06-24 2004-06-24 Astrazeneca Ab New compounds
JP2008530179A (ja) * 2005-02-16 2008-08-07 ソルベイ・フアーマシユーチカルズ・ベー・ブイ カンナビノイドcb2受容体モジュレーターとしての1h−イミダゾール誘導体
AR052666A1 (es) * 2005-02-16 2007-03-28 Solvay Pharm Bv Derivados de 1h-imidazol como moduladores del receptor cannabinoide cb2
DE102005008183A1 (de) 2005-02-23 2006-08-31 Bayer Healthcare Ag Heterocyclylamid-substituierte Imidazole
GB0508472D0 (en) * 2005-04-26 2005-06-01 Glaxo Group Ltd Compounds
EP1968946A4 (en) 2005-12-23 2010-05-05 Astrazeneca Ab IMIDAZOLE AS MODULATORS OF THE GABA B RECEPTOR
WO2008073461A2 (en) 2006-12-11 2008-06-19 Wyeth Ion channel modulators
GB0722075D0 (en) * 2007-11-09 2007-12-19 Smithkline Beecham Corp Compounds
HUE029871T2 (en) 2011-03-22 2017-04-28 Bayer Ip Gmbh N- (1,3,4-oxadiazol-2-yl) -arylcarboxylic acids and their use as herbicides
PL2772484T3 (pl) * 2011-10-18 2017-10-31 Astellas Pharma Inc Bicykliczny związek heterocykliczny
EP3127907A4 (en) * 2014-03-31 2018-04-04 Boston Biomedical, Inc. New tricyclic quinone derivative
GB201416754D0 (en) * 2014-09-23 2014-11-05 Mission Therapeutics Ltd Novel compounds
AU2016284398C1 (en) * 2015-06-22 2021-01-07 Sumitomo Dainippon Pharma Co., Ltd. 1,4-disubstituted imidazole derivative

Also Published As

Publication number Publication date
EP3312170A1 (en) 2018-04-25
US11661397B2 (en) 2023-05-30
KR20180028456A (ko) 2018-03-16
RU2741000C2 (ru) 2021-01-22
EP3312170A4 (en) 2018-12-12
CN107922386B (zh) 2021-04-02
JPWO2016208591A1 (ja) 2018-04-05
PH12017502388A1 (en) 2018-07-09
RU2018102087A (ru) 2019-07-23
US10807945B2 (en) 2020-10-20
WO2016208591A1 (ja) 2016-12-29
US20170166552A1 (en) 2017-06-15
US20180230085A1 (en) 2018-08-16
TW201713642A (zh) 2017-04-16
HK1248226A1 (zh) 2018-10-12
AU2016284398A1 (en) 2018-02-01
AU2016284398B2 (en) 2020-08-06
US20210171440A1 (en) 2021-06-10
CA2990583A1 (en) 2016-12-29
AU2016284398C1 (en) 2021-01-07
US9828362B2 (en) 2017-11-28
SG11201710695XA (en) 2018-01-30
CN107922386A (zh) 2018-04-17
JP6692354B2 (ja) 2020-05-13

Similar Documents

Publication Publication Date Title
RU2018102087A3 (ru)
BE2015C047I2 (ru)
BR0008604B1 (ru)
BR0009349B1 (ru)
BR0000126B1 (ru)
BR0000695B1 (ru)
BR0000763F1 (ru)
BR0001684B1 (ru)
BR0001810B1 (ru)
BR0002033B1 (ru)
BR0002402B1 (ru)
BR0002435B1 (ru)
BR0002694B1 (ru)
BR0002802B1 (ru)
BR0002874B1 (ru)
BR0003166B1 (ru)
BR0003189B1 (ru)
BR0003208B1 (ru)
BR0003401B1 (ru)
BR0003686B1 (ru)
BR0003746B1 (ru)
BR0003751B1 (ru)
BR0003928B1 (ru)
BR0004687B1 (ru)
BR0005041B1 (ru)